Covid-19: VC-backed healthtech deal values soar
Venture capital investment in healthtech hits $8.2 billion in the first quarter of 2020, the highest quarterly total on record, says Preqin; large deals continue to be made.
general partners
May 2020
Covid-19: Impact on alternative assets
The alternatives industry faces short-term disruption due to the Covid-19 pandemic, but the longer-term impact is more positive, says Preqin.
